Revvity | PKI - 销售收入



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 12.75B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


销售 更改 日
Agilent USD 1.84B 37M 2026-03
Align Technology USD 1.04B 10M 2026-03
Bio Techne USD 311.4M 15.5M 2026-03
Bio-Rad Laboratories USD 592.1M 101.1M 2026-03
Bruker USD 823.4M 153.8M 2026-03
Celltrion KRW 1.15T 180B 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 880M 81M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 28.31B 2.27B 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Illumina USD 1.09B 70M 2026-03
Intuitive Surgical USD 2.77B 100M 2026-03
IQVIA Holdings USD 4.15B 210M 2026-03
Kangmei Pharma CNY 1.08B 288.27M 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Laboratory Of America USD 3.54B 20M 2026-03
Medical Developments International AUD 21.57M 12.04M 2025-12
Mesa Laboratories USD 62.84M 5.01M 2024-12
Mettler Toledo International USD 947.13M 182.87M 2026-03
Myriad Genetics USD 200.4M 9.4M 2026-03
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Pharma Mar EUR 42.9M 47.3M 2026-03
Qiagen NV USD 419.22M 38.16M 2026-03
Quest Diagnostics USD 2.9B 90M 2026-03
Quidel USD 620M 104M 2026-03
Repligen USD 194M 3.91M 2026-03
Revvity USD 711M 61.06M 2026-03
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Tilray USD 217.51M 74.75M 2025-12
Waters USD 1.27B 338M 2026-03
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03